Mironid LoAc Phase 1 dosing has begun: the first-in-class PDE4 activator for ADPKD is being tested for safety and pharmacokinetics in healthy volunteers.
DaltonTx antibody discovery tools combine AI design, structure prediction and validation in one workflow that evaluates millions of sequences in hours.
Vetter is expanding its commercial manufacturing network with plans to add ten new filling lines as pharmaceutical and biotechnology companies seek greater production capacity for increasingly complex drug products. The…
Firefly Neuroscience and NeuroSigma are joining forces to expand clinician awareness and patient access to a non-drug treatment option for children with attention-deficit/hyperactivity disorder (ADHD). The strategic partnership will connect…
InSilicoTrials has joined a research team led by Sage Bionetworks that has received an award from the Advanced Research Projects Agency for Health (ARPA-H) under its Critical Illness Immunological Reprogramming…
Grünenthal and DKSH are expanding their commercial partnership in Asia-Pacific through a new agreement covering four pain medicines, as pharmaceutical companies increasingly look to established regional networks to improve access…
The Marsico Pancreatic Cancer Initiative at the University of Colorado Anschutz is expanding into a broader multi-institutional research effort designed to give scientists a deeper view of pancreatic ductal adenocarcinoma…
Sun Pharmaceutical Industries has entered into an exclusive licensing agreement with LIB Therapeutics to commercialize and manufacture lerodalcibep across global markets outside the United States and China. The agreement gives…